Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 62559-490

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 62559-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrop-structure.jpg (Atrop Structure)

FDA Label Image

Diphen-structure.jpg (Diphen Structure)

FDA Label Image

Ani.jpg (Ani)

FDA Label Image

Image 01

Image 01
This is a medication for oral use only, and it is available only with a prescription. Each tablet contains 2.5 mg of diphenoxylate hydrochloride USP and 0.025 mg of atropine sulfate USP. The tablet should be stored in a controlled room temperature. It is not intended for use in children under 6 years of age. The medication has the potential to become habit-forming, and patients should be warned not to exceed the recommended dosage. It also should be kept out of reach of children in a well-closed container. The prescribing information should be consulted for dosage. The medication is manufactured by ANI Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.